SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-19-000052
Filing Date
2019-08-20
Accepted
2019-08-20 16:16:19
Documents
2
Period of Report
2019-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156633216383352.html 4  
1 FORM 4 wf-form4_156633216383352.xml 4 4313
2 POA - MANCHESTER poa-manchester.htm EX-24 3337
  Complete submission text file 0001447028-19-000052.txt   9057
Mailing Address
Business Address
MANCHESTER KEITH S (Reporting) CIK: 0001244828 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 191039686

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations